Quoted Micro 8 June 2026
AQUIS STOCK EXCHANGE Incanthera (INC) is acquiring skincare brand Enielle for up to 54 million shares at 2p each depending on performance and its owner and boss Stuart Robertson will become Incanthera chief executive, taking over from Dr Simon Ward who will remain on the board. Tim McCarthy is stepping down as executive chairman. Enielle […]
Quoted Micro 4 May 2026
AQUIS STOCK EXCHANGE Audit and assurance services provider Adsure Services (ADS) is increasing customer numbers and market share in the housing sector and education has also been a strong market. Other markets have been weaker. Working capital was reduced. Ajax Resources (AJAX) has made a £200,000 strategic investment in Reveille Resources, taking a 25% stake […]
Quoted Micro 20 April 2026
AQUIS STOCK EXCHANGE Oscillate (SRVL) is raising £2.96m at 22.5p/share ahead of joining AIM on 27 April. This values the mining company, which is changing its name to Serval Resources, at £7.6m. Equipmake (EQIP) has announced a further £950,000 order with Agrale for electric drivetrain systems for nine buses in South America. They will be […]
Quoted Micro 8 December 2025
AQUIS STOCK EXCHANGE Amazing AI (AAI), whose shares are suspended because its corporate adviser has resigned, is asking for shareholder approval to leave Aquis. Considering the negative publicity this is not a surprise. Delta Gold Technologies (DQG) joined Aquis on 1 December 2025 when it raised £2.5m at 10p/share. The company is developing quantum computing […]
Quoted Micro 8 September 2025
AQUIS STOCK EXCHANGE AI technology developer Astrid Intelligence (ASTR) moved from the Main Market to the Access segment of Aquis on 3 September. The company was previously a CBD and health products retailer known as Cellular Goods and most recently it was called Cel AI. It is developing autonomous AI agents that provide personalised wellness […]
Quoted Micro 21 July 2025
AQUIS STOCK EXCHANGE Probiotics developer ProBiotix Health (LON: PBX) increased interim revenues by one-third to £1.34m and the loss was reduced. The first orders have been delivered to Kemin China Technology. The current order book is at record levels. There was £1.3m in cash at the end of June 2025. The full interims will be […]
Quoted Micro 19 May 2025
AQUIS STOCK EXCHANGE Time to Act (TTA) is raising a minimum of £264,000 at 40p/share. VSA Capital has set a target share price of 118p. Diffusion Alloys is a coatings business, and the customer base includes hydrogen, nuclear and fuel cell businesses. Another subsidiary, GreenSpur is developing axial flux technology. This business hopes to generate […]
Quoted Micro 21 October 2024
AQUIS STOCK EXCHANGE ProBiotix Health (PBX) has sent out a circular for the requisitioned general meeting on 1 November. The meeting has been requisitioned by Seneca Partners and related investors that hold 5.46% in total. Seneca Partners is also an investor in AIM-quoted OptiBiotix Health (LON: OPTI), which is also unhappy with the current management, […]
Quoted Micro 18 September 2023
AQUIS STOCK EXCHANGE An update on the Amapa iron ore project in Brazil from Cadence Minerals (LON: KDNC) says permitting times for the mine and related logistics should be reduced to 12-16 months. An environmental control plan is required to obtain the permits. This will enable a funding decision for the project. Investee company Hastings […]
Quoted Micro 1 May 2023
AQUIS STOCK EXCHANGE Technology investment company Asimilar (ASLR) is leaving AIM, but it will retain its Aquis quotation. Trading in the shares recommenced following the publication of the latest accounts. Chris Akers raised his shareholding from 9.13% to 10.3% and that helped the share price to recover from its low during the week. At the […]